Xtandi Uniunea Europeană - suedeză - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostatiska neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Hydrocortisone aceponate Ecuphar (previously Cortacare) Uniunea Europeană - suedeză - EMA (European Medicines Agency)

hydrocortisone aceponate ecuphar (previously cortacare)

ecuphar - hydrokortisonacceponat - kortikosteroider, dermatologiska preparat - hundar - för symptomatisk behandling av inflammatoriska och pruritiska dermatoser hos hundar. for alleviation of clinical signs associated with atopic dermatitis in dogs.

Byannli (previously Paliperidone Janssen-Cilag International) Uniunea Europeană - suedeză - EMA (European Medicines Agency)

byannli (previously paliperidone janssen-cilag international)

janssen-cilag international n.v.   - paliperidonpalmitat - schizofreni - neuroleptika - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Suiseng Diff/A Uniunea Europeană - suedeză - EMA (European Medicines Agency)

suiseng diff/a

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - grisar - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Mykofenolatmofetil Orifarm 250 mg Kapsel, hård Suedia - suedeză - Läkemedelsverket (Medical Products Agency)

mykofenolatmofetil orifarm 250 mg kapsel, hård

orifarm ab - mykofenolatmofetil - kapsel, hård - 250 mg - natriumlaurilsulfat hjälpämne; propylenglykol hjälpämne; mykofenolatmofetil 250 mg aktiv substans

Kagitz 400 mg Depottablett Suedia - suedeză - Läkemedelsverket (Medical Products Agency)

kagitz 400 mg depottablett

aristo pharma gmbh - kvetiapinfumarat - depottablett - 400 mg - kvetiapinfumarat 460,54 mg aktiv substans; laktosmonohydrat hjälpämne

Kagitz 50 mg Depottablett Suedia - suedeză - Läkemedelsverket (Medical Products Agency)

kagitz 50 mg depottablett

aristo pharma gmbh - kvetiapinfumarat - depottablett - 50 mg - laktosmonohydrat hjälpämne; kvetiapinfumarat 57,568 mg aktiv substans

Kagitz 300 mg Depottablett Suedia - suedeză - Läkemedelsverket (Medical Products Agency)

kagitz 300 mg depottablett

aristo pharma gmbh - kvetiapinfumarat - depottablett - 300 mg - kvetiapinfumarat 345,405 mg aktiv substans; laktosmonohydrat hjälpämne

Tareg 160 mg Filmdragerad tablett Suedia - suedeză - Läkemedelsverket (Medical Products Agency)

tareg 160 mg filmdragerad tablett

paranova läkemedel ab - valsartan - filmdragerad tablett - 160 mg - valsartan 160 mg aktiv substans - valsartan

Diovan 160 mg Filmdragerad tablett Suedia - suedeză - Läkemedelsverket (Medical Products Agency)

diovan 160 mg filmdragerad tablett

cross pharma ab - valsartan - filmdragerad tablett - 160 mg - valsartan 160 mg aktiv substans - valsartan